AI
TMO icon

AdvisorShares Investments’s Thermo Fisher Scientific TMO Stock Holding History

AdvisorShares Investments’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.58M Sell
11,351
-1,104
-9% -$599K 1.02% 29
2025
Q4 		$7.22M Sell
12,455
-1,021
-8% -$577K 1.2% 19
2025
Q3 		$6.54M Sell
13,476
-175
-1% -$81.5K 1.07% 24
2025
Q2 		$5.53M Buy
13,651
+325
+2% +$136K 1% 28
2025
Q1 		$6.44M Sell
13,326
-125
-0.9% -$67.7K 1.26% 26
2024
Q4 		$7M Buy
13,451
+2,316
+21% +$1.27M 1.35% 22
2024
Q3 		$6.89M Sell
11,135
-634
-5% -$375K 1.32% 14
2024
Q2 		$6.38M Buy
11,769
+1,558
+15% +$893K 1.11% 17
2024
Q1 		$5.93M Buy
10,211
+3,740
+58% +$2.1M 1% 14
2023
Q4 		$3.43M Buy
6,471
+1,785
+38% +$864K 0.8% 19
2023
Q3 		$2.37M Buy
4,686
+272
+6% +$145K 0.63% 29
2023
Q2 		$2.3M Buy
4,414
+1,088
+33% +$587K 0.66% 27
2023
Q1 		$1.92M Sell
3,326
-723
-18% -$408K 0.6% 25
2022
Q4 		$2.23M Buy
4,049
+1,939
+92% +$1.03M 0.63% 10
2022
Q3 		$1.07M Sell
2,110
-1,454
-41% -$814K 0.29% 33
2022
Q2 		$1.94M Buy
3,564
+1,422
+66% +$783K 0.54% 15
2022
Q1 		$1.26M Buy
2,142
+184
+9% +$106K 0.21% 36
2021
Q4 		$1.31M Sell
1,958
-325
-14% -$203K 0.16% 69
2021
Q3 		$1.3M Hold
2,283
– – 0.21% 66
2021
Q2 		$1.15M Buy
2,283
+126
+6% +$59.5K 0.16% 79
2021
Q1 		$984K Buy
2,157
+128
+6% +$61.1K 0.12% 89
2020
Q4 		$945K Buy
2,029
+190
+10% +$89.1K 0.22% 81
2020
Q3 		$812 Sell
1,839
-123
-6% -$50.8K 0.04% 79
2020
Q2 		$711K Sell
1,962
-246
-11% -$82.5K 0.3% 79
2020
Q1 		$626K Sell
2,208
-123
-5% -$38.8K 0.54% 43
2019
Q4 		$757K Buy
+2,331
New +$707K 0.47% 81

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AdvisorShares Investments's TMO Position: Q1 2026 in Review

AdvisorShares Investments reduced its Thermo Fisher Scientific (TMO) stake by 8.9% in Q1 2026, selling an estimated $599K and leaving 11,351 shares worth $5.58M. The position accounts for 1.02% of the portfolio, ranked #29.

AdvisorShares Investments first reported a position in TMO in Q4 2019 and has held it in 26 quarters since. The position peaked at $7.22M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • AdvisorShares Investments held 11,351 shares of Thermo Fisher Scientific worth $5.58M as of Q1 2026.
  • AdvisorShares Investments sold 1,104 Thermo Fisher Scientific shares in Q1 2026, an estimated $599K.
  • Thermo Fisher Scientific made up 1.02% of AdvisorShares Investments's portfolio in Q1 2026, its #29 holding.
  • AdvisorShares Investments first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 26 quarters since.
  • AdvisorShares Investments's Thermo Fisher Scientific position peaked at $7.22M in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on AdvisorShares Investments's 13F filing for Q1 2026, filed 28 Apr 2026.